This inventor holds 2 USPTO granted patents. Top assignees: Ciba-Geigy Ag, Isis Pharmaceuticals, Inc., Novartis Corporation. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 595 
1 out of 1,035 
1 out of 166 
Years Active: 1997-2000
Title: Jacques Lebreton: Innovator in Oligonucleotide Technology
Introduction
Jacques Lebreton is a notable inventor based in Marseilles, France. He has made significant contributions to the field of oligonucleotide technology, holding a total of 2 patents. His work has had a lasting impact on the scientific community and the pharmaceutical industry.
Latest Patents
Lebreton's latest patents focus on modified oligonucleotides, specifically backbone modified oligonucleotide analogs. These innovations are crucial for advancing genetic research and therapeutic applications.
Career Highlights
Throughout his career, Jacques Lebreton has worked with prominent companies such as Ciba-Geigy AG and Isis Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his expertise in oligonucleotide technology.
Collaborations
Lebreton has collaborated with esteemed colleagues, including Alain De Mesmaeker and Adrian Waldner. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Jacques Lebreton's contributions to oligonucleotide technology and his collaborations with leading professionals highlight his importance in the field. His work continues to influence advancements in genetic research and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile